Laser and surgery for glaucoma
When drops are not enough, or are not the best first step, pressure is lowered by laser or by an operation. Each procedure acts at a known point: it helps aqueous through the meshwork, bypasses the meshwork altogether, bypasses the pupil, or reduces how much aqueous is made. This lesson explains what each one does, when it is chosen and what can go wrong.
Matching the procedure to the problem
The earlier lessons described three places where things go wrong: the trabecular meshwork resists outflow, the iris blocks access to the meshwork, or, rarely, pressure downstream is high. Procedures are easiest to remember by which of these they address.
| Procedure | How it lowers pressure | Main use |
|---|---|---|
| Selective laser trabeculoplasty | Improves outflow through the existing meshwork | First-line treatment of open-angle glaucoma and ocular hypertension |
| Laser peripheral iridotomy | Lets aqueous bypass the pupil, so the iris falls away from the angle | Angle closure with pupil block |
| Minimally invasive glaucoma surgery | Small devices or cuts that bypass the meshwork, usually into Schlemm's canal | Mild to moderate open-angle glaucoma, often with cataract surgery |
| Trabeculectomy | Creates a new channel from the anterior chamber to the space under the conjunctiva | Advanced or progressing glaucoma |
| Tube shunt | A tube carries aqueous to a plate on the sclera further back | Failed trabeculectomy, scarred conjunctiva, difficult secondary glaucomas |
| Cyclodiode laser | Destroys part of the ciliary body to reduce aqueous production | Refractory glaucoma, or eyes with poor visual potential |
Under NICE NG81, 360 degree selective laser trabeculoplasty is offered first for newly diagnosed ocular hypertension that needs treatment and for open-angle glaucoma that is not advanced. Advanced glaucoma is offered surgery augmented with mitomycin C. Cyclodiode laser is an option after surgery has failed or when surgery is unsuitable or declined.
Laser trabeculoplasty
Selective laser trabeculoplasty (SLT) uses a frequency-doubled, Q-switched Nd:YAG laser at 532 nm, delivered through a goniolens to the trabecular meshwork. The pulses are extremely short, about 3 nanoseconds, and the spot is large. Energy is absorbed by pigmented meshwork cells but the pulse ends before heat can spread to neighbouring tissue. That is the meaning of selective: there is no burn and no scar.
The laser does not drill holes. Its effect is biological. The treated cells release signals that recruit macrophages and trigger remodelling of the extracellular matrix in the meshwork, and outflow improves over the following weeks. Because the meshwork is not scarred, the treatment can be repeated when the effect fades, which NICE allows for.
It is an outpatient procedure under topical anaesthetic, taking a few minutes. A drop of apraclonidine or brimonidine is given beforehand to prevent a pressure spike. Side effects are usually limited to transient discomfort, blurred vision, light sensitivity and redness. Serious complications are rare.
The older argon laser trabeculoplasty lowers pressure to a similar degree, but it works by thermal burns that scar the meshwork, so it is less suited to repeating. Trabeculoplasty needs a visible, open angle. It is not used where the angle is closed by synechiae, or in neovascular or inflammatory glaucoma, and it does not work in angle recession. NICE does not recommend it first line in pigment dispersion syndrome.
Iridotomy, iridoplasty and cyclodiode
Laser peripheral iridotomy uses a Nd:YAG laser to punch a small hole through the peripheral iris. It treats and prevents pupil block and is covered in the lesson on angle closure. Laser iridoplasty places contraction burns on the peripheral iris to pull it out of the angle. It is used for plateau iris and to break an acute attack of angle closure that drugs have not controlled.
Cyclodiode (transscleral diode laser cyclophotocoagulation) is the one common procedure that works on inflow. A probe placed on the sclera just behind the limbus delivers 810 nm diode laser through the wall of the eye. This wavelength is absorbed by melanin in the pigmented ciliary epithelium, and the heat destroys part of the tissue that secretes aqueous.
Because it is destructive and its effect is hard to titrate, cyclodiode is generally reserved for glaucoma that has not responded to other treatment, for eyes with poor visual potential, and for relieving pain in a blind eye with high pressure. It can be repeated if the pressure is still too high. The risks are inflammation, loss of vision and hypotony, meaning a pressure too low to maintain the eye. In the worst case the eye shrinks (phthisis), but this is rare.
Trabeculectomy
Trabeculectomy is the standard drainage operation. It does not repair the meshwork. It creates a guarded opening so that aqueous leaves the anterior chamber by a new route.
- The conjunctiva is opened, usually under the upper lid.
- A partial-thickness flap is cut in the sclera at the limbus.
- Beneath the flap, a small block of tissue is removed to make an opening (ostium) into the anterior chamber.
- A small peripheral iridectomy is often made so that the iris cannot plug the opening.
- The scleral flap is sutured back, loosely enough to let aqueous seep around its edges but tightly enough to keep the anterior chamber formed. Releasable sutures allow the flow to be adjusted afterwards.
- The conjunctiva is closed watertight over the top.
Aqueous now passes through the ostium, under the flap, and collects beneath the conjunctiva as a low blister called the filtering bleb, from which it is absorbed. The flap is the guard: without it, flow would be uncontrolled and the eye would collapse.
The enemy of this operation is healing. The body treats the bleb as a wound, and fibroblasts scar the conjunctiva down to the sclera and close the channel. Antimetabolites are applied at surgery to prevent this. Mitomycin C, a DNA cross-linker that inhibits fibroblast proliferation, is applied to the sclera on a soaked sponge before the opening is made. 5-fluorouracil, a pyrimidine analogue that blocks DNA synthesis, can be used in the same way or injected under the conjunctiva afterwards. Scarring and failure are more likely after previous eye surgery, in neovascular and uveitic glaucoma, in black patients and in the young.
The bleb and its complications
Complications are best divided by time, and the early ones by whether the pressure is too low or too high.
| When | Problem | What is seen |
|---|---|---|
| Early, low pressure | Overfiltration or a leaking wound | Shallow anterior chamber, choroidal effusions, folds at the macula with blurred vision (hypotony maculopathy) |
| Early, high pressure with a shallow chamber | Suprachoroidal haemorrhage, pupil block or aqueous misdirection | A firm eye with a flat chamber, needing urgent assessment |
| Early, high pressure with a deep chamber | Flap too tight or ostium blocked | Flat bleb |
| Late | Bleb failure from scarring or encapsulation | Pressure rises again and the bleb is flat or walled off |
| Late | Bleb leak | Low pressure, with fluorescein showing aqueous streaming from the bleb |
| Late | Blebitis and bleb-related endophthalmitis | Red painful eye, discharge and falling vision |
| Late | Cataract | May develop or progress after surgery |
Bleb-related infection can occur days to years after surgery. Blebitis is infection confined to the bleb. If organisms enter the eye through the thin bleb wall it becomes endophthalmitis, which can destroy vision quickly. Risk factors include a leaking bleb, antimetabolite use and a bleb placed inferiorly, where it is not protected by the upper lid.
Tube shunts
A glaucoma drainage device has two parts: a fine tube placed in the anterior chamber and a plate sutured to the sclera between two rectus muscles, 8 to 10 mm behind the limbus. Aqueous runs down the tube to the plate. Over about 4 to 6 weeks a fibrous capsule forms around the plate, and it is this capsule that regulates flow in the long term. In effect the tube makes a bleb further back, where conjunctival scarring at the limbus does not matter.
Devices are valved or non-valved. A valved device, such as the Ahmed valve, opens only above a set pressure and so can work from the first day with less risk of early hypotony. A non-valved device, such as the Baerveldt or Molteno implant, has no built-in resistance, so the tube is tied off or stented until the capsule has formed.
Tubes are chosen when a trabeculectomy has failed or is likely to fail: scarred conjunctiva, neovascular and other secondary glaucomas, and glaucoma in children after angle surgery has failed. Their particular complications are hypotony, damage to the corneal endothelium if the tube sits too far forward, erosion of the tube through the conjunctiva with a risk of infection, and double vision when the plate interferes with an eye muscle.
Minimally invasive glaucoma surgery in outline
Minimally invasive glaucoma surgery (MIGS) is a family of procedures designed to fill the gap between drops and laser on one side and trabeculectomy on the other. They share an approach from inside the eye through a small corneal incision, little disturbance of tissue, quick recovery and a much lower risk of serious complications such as hypotony and choroidal effusion or haemorrhage. The price is a more modest fall in pressure.
- Trabecular bypass: a tiny stent, such as the iStent or Hydrus, is placed through the meshwork into Schlemm's canal, or a strip of meshwork is removed or the canal dilated. This bypasses the main site of resistance.
- Suprachoroidal devices direct aqueous into the space between sclera and choroid.
- Subconjunctival devices, such as the Xen gel stent, drain to a bleb. Whether these truly count as minimally invasive is debated, because they form a bleb with the risks that brings.
They suit mild to moderate open-angle glaucoma and are very often combined with cataract surgery, since the eye is already open. They are not a substitute for trabeculectomy when a very low pressure is needed in advanced disease. Cataract extraction on its own also lowers pressure, most of all in angle closure, where removing the lens opens the angle.
Summary
- Selective laser trabeculoplasty uses short 532 nm pulses to stimulate the meshwork without scarring it, and can be repeated.
- NICE offers 360 degree selective laser trabeculoplasty first for ocular hypertension needing treatment and for open-angle glaucoma that is not advanced.
- Laser peripheral iridotomy relieves pupil block, and laser iridoplasty treats plateau iris.
- Cyclodiode laser destroys part of the ciliary body to reduce aqueous production and is reserved for refractory disease or eyes with poor visual potential.
- Trabeculectomy drains aqueous under a partial-thickness scleral flap into a subconjunctival filtering bleb.
- Mitomycin C and 5-fluorouracil are antimetabolites used to stop the bleb scarring.
- Early complications of trabeculectomy include hypotony with a shallow chamber and choroidal effusions.
- A red eye in a patient with a bleb is blebitis or endophthalmitis until proved otherwise.
- Tube shunts drain aqueous to a plate behind the limbus and are used when trabeculectomy has failed or is likely to fail.
- Minimally invasive procedures are safer but lower pressure less, and are often combined with cataract surgery.
Check yourself
Quick recall on this lesson. These are easier than the question bank.
Written for revision. It is not a source of clinical advice, and guidance changes.